Scholarlink

<p>Cyclodextrins (CDs) are widely deployed to improve the performance of poorly water soluble drugs, yet their role is still often framed narrowly as empirical “solubilizers.” This review reframes CDs as predictable stabilizers by connecting host–guest thermodynamics, stability constants (K<sub>1:1</sub>), complexation efficiency (CE), and ΔG<sub>bind</sub>, to quantitative kinetic outcomes that control exposure: supersaturation trajectories, induction time (t<sub>ind</sub>), and intrinsic dissolution rate (IDR). We synthesize evidence across native and derivative CDs (HP-β-CD, SBE-β-CD, RM-β-CD, γ-CD) and across hybrid architectures (nanosponges, polymer- and lipid based systems). A practitioner-oriented framework maps drug motifs and speciation at intestinal pH to derivative choice, then prescribes when to add polymers/surfactants to secure recrystallization resistance. Templates for measurement (phase solubility, t<sub>ind</sub>, IDR, XRPD/DSC) and a computational toolbox (docking → MD → ΔG estimation; QSPR/ML) translate ΔG/K/CE into effect sizes in log(S/S<sub>0</sub>) and t<sub>ind</sub>. We codify reporting standards (raw points, CE with CI, buffer/pH/ionic strength, DS/vendor) and common pitfalls (misreading AN/BS curvature, filter adsorption, confusing complex precipitation with drug recrystallization). The review culminates in decision trees and design rules that elevate CDs from trial and error excipients to mechanistically rational stabilizers, supporting robust and reproducible formulation design in oral delivery.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

From solubilizers to release stabilizers: mechanistic design rules for cyclodextrin-based oral drug delivery

  • 期刊论文

  • 发表日期：

    2026年6月3日

查看全文
  • Khaldoun A. Al-Sou’od,
  • Layan Alsoud

摘要

Cyclodextrins (CDs) are widely deployed to improve the performance of poorly water soluble drugs, yet their role is still often framed narrowly as empirical “solubilizers.” This review reframes CDs as predictable stabilizers by connecting host–guest thermodynamics, stability constants (K1:1), complexation efficiency (CE), and ΔGbind, to quantitative kinetic outcomes that control exposure: supersaturation trajectories, induction time (tind), and intrinsic dissolution rate (IDR). We synthesize evidence across native and derivative CDs (HP-β-CD, SBE-β-CD, RM-β-CD, γ-CD) and across hybrid architectures (nanosponges, polymer- and lipid based systems). A practitioner-oriented framework maps drug motifs and speciation at intestinal pH to derivative choice, then prescribes when to add polymers/surfactants to secure recrystallization resistance. Templates for measurement (phase solubility, tind, IDR, XRPD/DSC) and a computational toolbox (docking → MD → ΔG estimation; QSPR/ML) translate ΔG/K/CE into effect sizes in log(S/S0) and tind. We codify reporting standards (raw points, CE with CI, buffer/pH/ionic strength, DS/vendor) and common pitfalls (misreading AN/BS curvature, filter adsorption, confusing complex precipitation with drug recrystallization). The review culminates in decision trees and design rules that elevate CDs from trial and error excipients to mechanistically rational stabilizers, supporting robust and reproducible formulation design in oral delivery.

Graphical abstract